CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-18 | BAKER BROS. ADVISORS LP Director | Purchase | +253 | $369.34 | $93K | 193,186 |
| 2025-08-18 | BAKER BROS. ADVISORS LP Director | Purchase | +2,747 | $369.34 | $1.0M | 1,843,469 |
| 2025-08-18 | BAKER BROS. ADVISORS LP Director | Purchase | +506 | $371.01 | $188K | 193,692 |
| 2025-08-18 | BAKER BROS. ADVISORS LP Director | Purchase | +5,494 | $371.01 | $2.0M | 1,848,963 |
| 2025-08-18 | BAKER BROS. ADVISORS LP Director | Purchase | +933 | $372.16 | $347K | 194,625 |
| 2025-08-18 | BAKER BROS. ADVISORS LP Director | Purchase | +10,128 | $372.16 | $3.8M | 1,859,091 |
| 2025-08-18 | Kelley Shannon T General Counsel | Sale 10b5-1 | −458 | $358.66 | $164K | 10,019 |
| 2025-08-18 | Kelley Shannon T General Counsel | Sale 10b5-1 | −126 | $369.64 | $47K | 9,893 |
| 2025-08-18 | Kelley Shannon T General Counsel | Sale 10b5-1 | −84 | $370.06 | $31K | 9,809 |
| 2025-08-18 | Kelley Shannon T General Counsel | Sale 10b5-1 | −84 | $371.35 | $31K | 9,725 |
| 2025-08-18 | Kelley Shannon T General Counsel | Sale 10b5-1 | −252 | $372.44 | $94K | 9,473 |
| 2025-08-18 | Kelley Shannon T General Counsel | Sale 10b5-1 | −68 | $374.13 | $25K | 9,405 |
| 2025-08-18 | Kelley Shannon T General Counsel | Sale 10b5-1 | −190 | $375.75 | $71K | 9,215 |
| 2025-08-18 | Kelley Shannon T General Counsel | Sale 10b5-1 | −42 | $376.62 | $16K | 9,173 |
| 2025-08-15 | BATE KENNETH Director | Option exercise | +10,000 | $16.46 | $165K | 12,627 |
| 2025-08-15 | BATE KENNETH Director | Sale | −2,317 | $363.41 | $842K | 10,310 |
| 2025-08-15 | BATE KENNETH Director | Sale | −2,516 | $364.24 | $916K | 7,794 |
| 2025-08-15 | BATE KENNETH Director | Sale | −2,567 | $365.33 | $938K | 5,227 |
| 2025-08-15 | BATE KENNETH Director | Sale | −600 | $366.14 | $220K | 4,627 |
| 2025-08-15 | BATE KENNETH Director | Sale | −1,104 | $367.63 | $406K | 3,523 |
Page 17 of 82 · 1,629 trades